Literature DB >> 11110935

Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience.

K Lauerma1, P Niemi, H Hänninen, T Janatuinen, L M Voipio-Pulkki, J Knuuti, L Toivonen, T Mäkelä, M A Mäkijärvi, H J Aronen.   

Abstract

PURPOSE: To combine three magnetic resonance (MR) imaging modalities-dobutamine stress cine, first pass, and late contrast material-enhanced T1-weighted imaging-and to compare the results with 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in the assessment of unviable myocardium in coronary artery disease.
MATERIALS AND METHODS: Ten patients with multivessel coronary artery disease underwent MR imaging before and 6 months after bypass surgery. Left ventricular cine MR imaging was performed at rest and during dobutamine infusion. Inversion-recovery gradient-echo images were obtained to study myocardial contrast enhancement at first pass and 5 minutes later. FDG PET was performed with orally administered acipimox before surgery.
RESULTS: With dobutamine cine MR imaging, unviable myocardium was detected with a sensitivity of 79% and a specificity of 93%; postoperative wall thickening was the standard. First-pass analysis increased these values to 97% and 96%; analysis of late enhancement with T1-weighted imaging, to 62% and 98%. FDG PET had a sensitivity of 81% and a specificity of 86%.
CONCLUSION: The combination of first-pass enhancement analysis and wall motion assessment with stress significantly increases the specificity of MR imaging in the detection of unviable sectors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110935     DOI: 10.1148/radiology.217.3.r00dc18729

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization.

Authors:  M Gutberlet; M Fröhlich; S Mehl; H Amthauer; H Hausmann; R Meyer; H Siniawski; J Ruf; M Plotkin; T Denecke; B Schnackenburg; R Hetzer; R Felix
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

Review 2.  Characterization of myocardial viability using MR and CT imaging.

Authors:  Gabriele A Krombach; Thoralf Niendorf; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

3.  Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

4.  Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging.

Authors:  V Bodí; J Sanchis; M P López-Lereu; J Núñez; R Sanz; P Palau; C Gómez; D Moratal; F J Chorro; A Llácer
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

5.  Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.

Authors:  H Bülow; C Klein; I Kuehn; R Hollweck; S G Nekolla; K Schreiber; F Haas; J Böhm; B Schnackenburg; R Lange; M Schwaiger
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

6.  Temporal analysis of the depolarization wave of healed myocardial infarction in body surface potential mapping.

Authors:  Paula Vesterinen; Helena Hänninen; Milla Karvonen; Kirsi Lauerma; Miia Holmström; Markku Mäkijärvi; Heikki Väänänen; Jukka Nenonen; Toivo Katila; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

Review 7.  Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Authors:  Javier Sanz; Teresa Rius; Paola Kuschnir; Rafael Salguero Bodes; Michael Poon
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

8.  Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-11-01

Review 9.  Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

Review 10.  Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Authors:  Nuno Bettencourt; Amedeo Chiribiri; Andreas Schuster; Eike Nagel
Journal:  Curr Heart Fail Rep       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.